Table 4: Conceptual Agreement and Self Reported Overall Application of ASAS/EULAR Recommendations for the Management of AS

Item Mean SD
Overarching principles 8.24 2.61
Item-1 (General treatment) 9.50 1.30
Item-2 (Disease monitoring) 9.26 1.42
Item-3 (Non-pharmacological treatment) 9.60 1.19
Item-4 (Extra-articular manifestations and co-morbidities) 9.52 1.26
Item-5 (Non-steroidal anti-inflammatory drugs) 9.52 1.24
Item-6 (Analgesics) 7.89 2.80
Item-7 (Glucocorticoids) 8.97 1.90
Item-8 (Disease-modifying anti-rheumatic drugs) 7.85 2.76
Item-9 (Anti TNF therapy) 8.59 2.13
Item-10 (Surgey ) 8.38 2.19
Item-11 (Changes in the disease course) 9.50 1.19
Self-declared application of overall recommendations, % 75.71 21.20